For the roughly two million Americans living with a lower-limb amputation, the most common point of failure is not the prosthetic limb itself, but the socket that attaches it to the body. Daily changes in residual limb volume, driven by everything from hydration to activity, can turn a perfect morning fit into a painful, blistering ordeal by afternoon. Vessl Prosthetics, a Canadian medtech startup, is betting that a socket that automatically adjusts itself can solve this decades-old problem, and a growing list of clinics is lining up to see if they're right.
The Kinetic Wedge
Vessl's flagship product is the Kinn Automatic Volume Management System, a prosthetic socket that uses kinetic energy from a patient's gait to power a self-adjusting mechanism. The core idea is to eliminate the need for manual adjustments or adding and removing sock layers throughout the day, a routine that disrupts mobility and comfort. The company reports it has secured FDA clearance for the device and holds granted patents on the technology [MedTech Innovator YouTube, Apr 2026]. This regulatory and intellectual property foundation is a critical, non-negotiable first step for any novel medical hardware aiming for the U.S. market.
The company's early traction is measured in clinic partnerships rather than direct-to-consumer sales, a common and prudent path for regulated medical devices. Vessl reports a cooperative research agreement with the U.S. Department of Veterans Affairs and a commercial waitlist of 130 clinics [MedTech Innovator YouTube, Apr 2026]. For a pre-seed stage hardware company founded in 2022, this level of institutional interest is a strong signal of clinical need.
Funding and Founders
Vessl has raised a pre-seed round, with one disclosed portion totaling $250,000 [Preqin, 2025]. Investors include BioNext and Ontario’s Life Sciences Innovation Fund, which also provided a grant [MIX, Aug 2025]. The team has grown from three to seven full-time staff, adding prosthetists and engineers to support product development and the anticipated commercial rollout [MIX, Aug 2025].
The founding team, biomedical engineer Sydney Robinson and co-founder Oleksiy Zaika, identified the problem while observing patient challenges at a diabetes clinic in Hamilton, Ontario [Innovation Factory, 2023-2025]. Their clinical grounding is reflected in a product designed for integration into existing prosthetic care workflows, not as a standalone consumer gadget.
The Standard of Care Today
For a patient with a lower-limb amputation, today's standard of care for socket fit is largely manual and static. A prosthetist creates a custom socket, and the patient is then responsible for managing fit through a system of ply socks,fabric layers of varying thicknesses that are added or removed as the limb swells or shrinks. This process is imprecise, can cause skin breakdown, and requires patients to carry extra socks and frequently stop to adjust. For active individuals or those with conditions like diabetes that affect circulation, these fluctuations are more severe and the consequences of poor fit,including pain, wounds, and infection,are more serious. Vessl's bet is that automating this adjustment removes a significant daily burden and risk for this patient population.
The Path to Commercialization
With FDA clearance and a waitlist in hand, Vessl's next challenges are classic for medtech hardware: manufacturing scale and reimbursement. The company has not disclosed pricing, but gaining insurance coverage will be pivotal for adoption. The VA research agreement is a strategic asset here, as positive outcomes data from veterans' hospitals can be influential for both public and private payers.
The competitive landscape includes established players like Martin Bionics, which offers custom socket solutions, and other innovators in adjustable sockets. Vessl's differentiation rests on its fully automatic, kinetic-energy-driven mechanism, which it claims requires no patient intervention.
Key milestones to watch in the next 12 months will be:
- First commercial shipments. Moving the 130-clinic waitlist to paying customers.
- Reimbursement codes. Securing initial insurance coverage, likely starting with the VA system.
- Clinical data. Publishing early findings from the VA cooperative research agreement.
For patients who have long managed socket fit with a bag of socks and constant vigilance, a self-adjusting solution represents a fundamental improvement in quality of life. Vessl Prosthetics has cleared the first technical and regulatory hurdles. Now, it must prove that its kinetic socket can hold up under the weight of daily use, and that the healthcare system is willing to pay for it.
Sources
- [Preqin, 2025] Vessl Prosthetics Inc. Asset Profile | https://www.preqin.com/data/profile/asset/vessl-prosthetics-inc-/722081
- [Innovation Factory, 2023-2025] Vessl Prosthetics Inc. | https://innovationfactory.ca/clients/vessl-prosthetics-inc/
- [MedTech Innovator YouTube, Apr 2026] Vessl Prosthetics - Overview | https://www.youtube.com/watch?v=nn6piapIVYo
- [MIX, Aug 2025] MIX Profile: Sydney Robinson, Co-founder and CEO of Vessl Prosthetics | https://medicalinnovationxchange.com/2025/08/27/mix-profile-sydney-robinson-co-founder-and-ceo-of-vessl-prosthetics/
- [Vesslpro.com, retrieved 2026] About Vessl | https://www.vesslpro.com/about-us